◆ NeutralHNGEGMEDVCYTWST
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
Zacks Investment Research·
Hinge Health (HNGE) raised its 2026 revenue guidance to $856-$860M following a 53% Q2 revenue jump to $212.8M. The company is expanding beyond its core MSK platform into Migraine Care (450 clients, 5M lives) and acquiring Cylinder Health for $105M to accelerate GI expansion. While growth prospects remain strong with a 30.6% expected growth rate, continued product investments and integration costs could temper margin expansion.
Read Full Article at Zacks Investment Research →